GGrantIndex
Sort

51,593 grants matching hepatitis

HIV Disease Outcomes in Drug Users in Clinical Practice

$1,047,335
Richard Douglas Moore · Johns Hopkins University · R01 · FY2007 · DA

HCV replication and immunity

$1,047,020
Research Inst Nationwide Children'S Hosp · U19 · FY2003 · AI

Trans-NIH RNAi Facility (TNRF)

$1,046,097
Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2019 · TR

US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE)

$1,045,863
Juliet Iwelunmor · Washington University · U54 · FY2023 · CA

FOCUS

$1,045,488
Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch · U01 · FY2007 · HL

Center for Gastrointestinal Biology and Disease

$1,045,286
Robert S Sandler · Univ Of North Carolina Chapel Hill · P30 · FY2013 · DK

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,044,758
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Xenobiotic-Metabolizing Enzymes

$1,044,513
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE

$1,043,361
Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2008 · RR

Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)

$1,043,102
Philip Todd Korthuis · Oregon Health & Science University · U01 · FY2018 · TR

Virus-host interactions in hepatocarcinogenesis

$1,042,962
J.-H. James Ou · University Of Southern California · P01 · FY2011 · CA

Molecular Mechanisms of TGF-beta Signaling Pathway

$1,042,668
Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Biorepository for Genomic Medicine in diverse Communities

$1,042,587
Erwin P. Bottinger · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · HG

Reduce Transmission Risks &Improve HCV Treatment Access

$1,042,076
Johns Hopkins University · R01 · FY2002 · DA

Candidate selection of a LPAR1 antagonist for therapeutic application in NASH

$1,041,548
Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2024 · DK

Core B - Developmental

$1,041,383
Ira B Wilson · Miriam Hospital · P30 · FY2019 · AI

Clinical Validation Center for Hepatocellular Carcinoma

$1,041,376
Amit Singal · Ut Southwestern Medical Center · U01 · FY2023 · CA

CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE

$1,041,184
University Of North Carolina Chapel Hill · P30 · FY2005 · DK

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$1,041,025
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA

ASIAN AMERICAN NETWORK FOR CANCER AWARENESS RESEARCH & TRAINING

$1,041,004
Moon S Chen · University Of California At Davis · U01 · FY2007 · CA

Pathogenesis Of Enteric Viral Hepatitis

$1,040,807
Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam

$1,039,302
Don C Des Jarlais · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DA

Cancer stem cells and human liver cancer

$1,039,287
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Resource for NMR Molecular Imaging of Proteins

$1,038,960
Stanley J Opella · University Of California, San Diego · P41 · FY2012 · EB

HIV and HCC in Africa: The H2A Consortium

$1,038,176
Gregory D Kirk · Johns Hopkins University · U54 · FY2020 · CA